BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

MindFrame Inc. Announces CE Mark for New Capture(TM) LP Devices for Treatment of Patients Experiencing Ischemic Stroke


12/29/2011 6:14:43 AM

IRVINE, Calif.--(BUSINESS WIRE)--MindFrame, Inc. today announces that a CE mark was granted for a new series of MindFrame Capture LP devices. Part of the comprehensive portfolio of MindFrame Therapy Solutions, the low profile devices have been expanded to include a 4-mm diameter and shorter length sizes. The MindFrame Capture LP product portfolio can be uniquely deployed through smaller microcatheters to improve navigation through tortuous vessels. The MindFrame Capture LP 15-mm device was expressly engineered to address treatment in short segments of tortuous vessels. Rapid flow restoration and clot retrieval is essential to prevent irreversible deterioration of brain function in patients suffering from acute ischemic stroke.

Compatible with any microcatheter 10/14 or greater, MindFrame LP devices provide clinicians with the additional benefit of increased thrombus aspiration when needed, both locally and proximally, as a result of the reduced microcatheter size. The devices offer improved tensile strength and kink resistance for device durability, as well as enhanced trackability for precise placement and control.

“This represents another example of MindFrame’s commitment to rapid product development,” says Ken Charhut, president and CEO of MindFrame Inc. “Receiving the CE mark approval for the product portfolio expansion enables physicians to treat a majority of patients presenting with ischemic stroke by utilizing low-profile technology for more efficient navigation and better aspiration. MindFrame is committed to developing leading-edge devices that provide improved procedural and clinical outcomes for clinicians and their patients.”

MindFrame Capture LP is not approved for sale in the United States.

About MindFrame Inc.

MindFrame Inc. is a pioneer in developing optimized technologies for patients experiencing ischemic stroke. The breakthrough MindFrame Therapy Solutions portfolio comprises some of the most advanced device design technology that delivers exceptional rapid flow restoration and clot extraction intended to help clinicians provide improved clinical outcomes for their patients. For more information about the breakthrough MindFrame Capture LP state-of-the-art technologies, visit www.MindFrameInc.com.

Contact:

MindFrame, Inc.

Shannon Jacobs

949.271.1180

shannonj@devicepharm.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES